Additionally, the team assessed sarcopenia status by handgrip strength, skeletal muscle index and calf circumference. Results accounted for physical activity levels, smoking, alcohol intake,...
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...